BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30702752)

  • 21. Characterization of post-transfusion anti-FEA 1 alloantibodies in transfusion-naive FEA 1-negative cats.
    Cannavino A; LeVine D; Blais MC
    J Feline Med Surg; 2022 Jun; 24(6):e124-e130. PubMed ID: 35510900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemolytic disease of the newborn because of rare anti-Vel.
    van Gammeren AJ; Overbeeke MA; Idema RN; van Beek RH; Ten Kate-Booij MJ; Ermens AA
    Transfus Med; 2008 Jun; 18(3):197-8. PubMed ID: 18598283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a new monoclonal anti-k (anti-KEL2) reagent.
    Strobel E
    Clin Lab; 2010; 56(9-10):385-9. PubMed ID: 21086783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the presence or absence of J chain on expression of recombinant anti-Kell immunoglobulin M.
    Gilmour JE; Pittman S; Nesbitt R; Scott ML
    Transfus Med; 2008 Jun; 18(3):167-74. PubMed ID: 18598279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocyte monolayer assay in pre-transfusion testing: A magic key in transfusing patients with recurrent bad cross-match due to alloimmunization.
    El-Sayed HAN; Abdollah MRA; Raafat SN; Ragab D
    J Immunol Methods; 2021 May; 492():112968. PubMed ID: 33465386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human monoclonal antibody to high-frequency red cell antigen Jra.
    Miyazaki T; Kwon KW; Yamamoto K; Tone Y; Ihara H; Kato T; Ikeda H; Sekiguchi S
    Vox Sang; 1994; 66(1):51-4. PubMed ID: 8146983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SMIM1, carrier of the Vel blood group, is a tail-anchored transmembrane protein and readily forms homodimers in a cell-free system.
    Nylander A; Leznicki P; Vidovic K; High S; Olsson ML
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32301496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An infant girl with severe autoimmune hemolytic anemia: apparent anti-Vel specificity.
    Becton DL; Kinney TR
    Vox Sang; 1986; 51(2):108-11. PubMed ID: 3776136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review: monoclonal reagents and detection of unusual or rare phenotypes or antibodies.
    Moulds MK
    Immunohematology; 2006; 22(2):52-63. PubMed ID: 16813466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system].
    León-González G; Cruz C
    Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of murine monoclonal antibodies in RBC phenotyping of DAT-positive samples.
    Lee E; Hart K; Burgess G; Halverson GR; Reid ME
    Immunohematology; 2006; 22(4):161-5. PubMed ID: 17430074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMIM1 variants rs1175550 and rs143702418 independently modulate Vel blood group antigen expression.
    Christophersen MK; Jöud M; Ajore R; Vege S; Ljungdahl KW; Westhoff CM; Olsson ML; Storry JR; Nilsson B
    Sci Rep; 2017 Jan; 7():40451. PubMed ID: 28084402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The c.64_80del SMIM1 allele is segregating in the Hutterite population.
    Coghlan G; Zelinski T
    Transfusion; 2016 Apr; 56(4):946-9. PubMed ID: 26666208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of transfected cell lines for the detection of alloantibodies against human neutrophil antigen-3.
    Bayat B; Tjahjono Y; Werth S; Berghöfer H; Reil A; Kroll H; Sachs UJ; Santoso S
    Transfusion; 2012 Mar; 52(3):613-21. PubMed ID: 21883263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines.
    Lin M; Xu X; Lee HL; Liang DC; Santoso S
    Transfusion; 2018 Jan; 58(1):189-195. PubMed ID: 29030871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal blood group antibodies.
    Voak D
    Beitr Infusionsther; 1989; 24():200-13. PubMed ID: 2481540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMIM1 intron 2 gene variations leading to variability in Vel antigen expression among Brazilian blood donors.
    Dezan MR; Costa-Neto A; Gomes CN; Ribeiro IH; Oliveira VB; Conrado MCAV; Oliveira TGM; Carvalho MLP; Aranha AF; Bosi SRA; Salles NA; Krieger JE; Pereira AC; Sabino EC; Rocha V; Mendrone-Junior A; Dinardo CL; Levi JE
    Blood Cells Mol Dis; 2019 Jul; 77():23-28. PubMed ID: 30939337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.
    Strupp A; Cash K; Uehlinger J
    Transfusion; 1998; 38(11-12):1022-5. PubMed ID: 9838931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-Ge2 in a Ge: -2, -3 patient].
    Durán-Suárez JR; Sánchez C; Herrero E; Hernández Sánchez JM
    Sangre (Barc); 1991 Aug; 36(4):319-21. PubMed ID: 1776112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.